hydroxy Search Results


98
Gold Biotechnology Inc d luciferin
D Luciferin, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d luciferin/product/Gold Biotechnology Inc
Average 98 stars, based on 1 article reviews
d luciferin - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

95
Chem Impex International thymidine analog 5 bromo2
Thymidine Analog 5 Bromo2, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thymidine analog 5 bromo2/product/Chem Impex International
Average 95 stars, based on 1 article reviews
thymidine analog 5 bromo2 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

92
Croda International Plc r rac lpg
R Rac Lpg, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/r rac lpg/product/Croda International Plc
Average 92 stars, based on 1 article reviews
r rac lpg - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

96
Croda International Plc 845875p
845875p, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/845875p/product/Croda International Plc
Average 96 stars, based on 1 article reviews
845875p - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

95
Croda International Plc 1 arachidonoyl 2 hydroxy sn glycero 3 phosphate
1 Arachidonoyl 2 Hydroxy Sn Glycero 3 Phosphate, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1 arachidonoyl 2 hydroxy sn glycero 3 phosphate/product/Croda International Plc
Average 95 stars, based on 1 article reviews
1 arachidonoyl 2 hydroxy sn glycero 3 phosphate - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

95
Croda International Plc lpa
Lpa, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lpa/product/Croda International Plc
Average 95 stars, based on 1 article reviews
lpa - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
Croda International Plc dioleoyl sn glycero 3 phospho l serinen
Dioleoyl Sn Glycero 3 Phospho L Serinen, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dioleoyl sn glycero 3 phospho l serinen/product/Croda International Plc
Average 93 stars, based on 1 article reviews
dioleoyl sn glycero 3 phospho l serinen - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

95
Croda International Plc 855575c
855575c, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/855575c/product/Croda International Plc
Average 95 stars, based on 1 article reviews
855575c - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

94
Croda International Plc lpc
(Related to ). (A and B) Depletion of meosin by siRNA in hOC. Western blot analysis of moesin and activated ERM (P-ERM) expression level in hOC after treatment on day 0 with nontargeting siRNA (siCTL) or siRNA targeting moesin (siM), on days 3, 6, and 10 of differentiation. (A) Representative experiment and (B) quantification of moesin (left) and P-ERM (right) expression level normalized to actin. Each circle represents a single donor, n = 7–8, SDs are shown. (C–E) Effect of <t>LPC</t> treatment on hOC fusion and activated ERM expression level (P-ERM). On day 6 of differentiation, hOC were treated with LPC (+LPC, 17 h), or treated and then washed (90 min) (+/− LPC) or no treated (control, CTL). (C and D) Microscopy analysis of hOC fusion. (C) Representative microscopy images: F-actin (phalloidin, white) and nuclei (DAPI, cyan). Scale bar, 50 µm. (D) Quantification of fusion index (left) and area occupied by multinucleated OC (right). Each circle represents a single donor, n =3–4. (E) Western blot analysis of P-ERM expression level in each condition, normalized to actin. Representative blot (left panel) and quantification (right panel). Each circle represents a single donor, n = 4. (F) P-ERM signal by western blot analysis in murine inflammatory osteoclasts (DC-OC) versus control osteoclasts (MN-OC). See material and methods. Representative blot of P-ERM expression level in each condition (upper panel) and quantification of P-ERM expression level, normalized to actin (lower panel). Each circle represents a single mouse, n = 4, SDs are shown. (G–J) Effect of HIV infection on activated ERM expression level (P-ERM) in hOC (G and H) and macrophages (I and J). (G and H) On day 6 of differentiation, hOC were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 8 days after infection. (G) Quantification of the fusion index (each circle represents a single donor, n = 4) and (H) representative western blot analysis of P-ERM expression level (left), and quantification of P-ERM expression level, normalized to actin (right, each circle represents a single donor, n = 5, SD is shown). (I and J) On day 6 of differentiation, macrophages were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 7 days after infection. (I) Quantification of the fusion index (each circle represents a single donor, n = 4) and (J) representative western blot analysis of P-ERM expression level (left) and quantification of P-ERM expression level, normalized to actin (right). Each circle represents a single donor, n = 6, SDs are shown. Predicted molecular weights are indicated on western blots. Statistical analyses: (D and E) one-way ANOVA and then Tukey multiple comparison tests. P value is indicated on the graphs, *P ≤ 0.05. Source data are available for this figure: .
Lpc, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lpc/product/Croda International Plc
Average 94 stars, based on 1 article reviews
lpc - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

95
Croda International Plc monoacylglycerosphosphoethanolamine lpe
(Related to ). (A and B) Depletion of meosin by siRNA in hOC. Western blot analysis of moesin and activated ERM (P-ERM) expression level in hOC after treatment on day 0 with nontargeting siRNA (siCTL) or siRNA targeting moesin (siM), on days 3, 6, and 10 of differentiation. (A) Representative experiment and (B) quantification of moesin (left) and P-ERM (right) expression level normalized to actin. Each circle represents a single donor, n = 7–8, SDs are shown. (C–E) Effect of <t>LPC</t> treatment on hOC fusion and activated ERM expression level (P-ERM). On day 6 of differentiation, hOC were treated with LPC (+LPC, 17 h), or treated and then washed (90 min) (+/− LPC) or no treated (control, CTL). (C and D) Microscopy analysis of hOC fusion. (C) Representative microscopy images: F-actin (phalloidin, white) and nuclei (DAPI, cyan). Scale bar, 50 µm. (D) Quantification of fusion index (left) and area occupied by multinucleated OC (right). Each circle represents a single donor, n =3–4. (E) Western blot analysis of P-ERM expression level in each condition, normalized to actin. Representative blot (left panel) and quantification (right panel). Each circle represents a single donor, n = 4. (F) P-ERM signal by western blot analysis in murine inflammatory osteoclasts (DC-OC) versus control osteoclasts (MN-OC). See material and methods. Representative blot of P-ERM expression level in each condition (upper panel) and quantification of P-ERM expression level, normalized to actin (lower panel). Each circle represents a single mouse, n = 4, SDs are shown. (G–J) Effect of HIV infection on activated ERM expression level (P-ERM) in hOC (G and H) and macrophages (I and J). (G and H) On day 6 of differentiation, hOC were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 8 days after infection. (G) Quantification of the fusion index (each circle represents a single donor, n = 4) and (H) representative western blot analysis of P-ERM expression level (left), and quantification of P-ERM expression level, normalized to actin (right, each circle represents a single donor, n = 5, SD is shown). (I and J) On day 6 of differentiation, macrophages were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 7 days after infection. (I) Quantification of the fusion index (each circle represents a single donor, n = 4) and (J) representative western blot analysis of P-ERM expression level (left) and quantification of P-ERM expression level, normalized to actin (right). Each circle represents a single donor, n = 6, SDs are shown. Predicted molecular weights are indicated on western blots. Statistical analyses: (D and E) one-way ANOVA and then Tukey multiple comparison tests. P value is indicated on the graphs, *P ≤ 0.05. Source data are available for this figure: .
Monoacylglycerosphosphoethanolamine Lpe, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoacylglycerosphosphoethanolamine lpe/product/Croda International Plc
Average 95 stars, based on 1 article reviews
monoacylglycerosphosphoethanolamine lpe - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

98
Gold Biotechnology Inc d luciferin potassium salt
(Related to ). (A and B) Depletion of meosin by siRNA in hOC. Western blot analysis of moesin and activated ERM (P-ERM) expression level in hOC after treatment on day 0 with nontargeting siRNA (siCTL) or siRNA targeting moesin (siM), on days 3, 6, and 10 of differentiation. (A) Representative experiment and (B) quantification of moesin (left) and P-ERM (right) expression level normalized to actin. Each circle represents a single donor, n = 7–8, SDs are shown. (C–E) Effect of <t>LPC</t> treatment on hOC fusion and activated ERM expression level (P-ERM). On day 6 of differentiation, hOC were treated with LPC (+LPC, 17 h), or treated and then washed (90 min) (+/− LPC) or no treated (control, CTL). (C and D) Microscopy analysis of hOC fusion. (C) Representative microscopy images: F-actin (phalloidin, white) and nuclei (DAPI, cyan). Scale bar, 50 µm. (D) Quantification of fusion index (left) and area occupied by multinucleated OC (right). Each circle represents a single donor, n =3–4. (E) Western blot analysis of P-ERM expression level in each condition, normalized to actin. Representative blot (left panel) and quantification (right panel). Each circle represents a single donor, n = 4. (F) P-ERM signal by western blot analysis in murine inflammatory osteoclasts (DC-OC) versus control osteoclasts (MN-OC). See material and methods. Representative blot of P-ERM expression level in each condition (upper panel) and quantification of P-ERM expression level, normalized to actin (lower panel). Each circle represents a single mouse, n = 4, SDs are shown. (G–J) Effect of HIV infection on activated ERM expression level (P-ERM) in hOC (G and H) and macrophages (I and J). (G and H) On day 6 of differentiation, hOC were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 8 days after infection. (G) Quantification of the fusion index (each circle represents a single donor, n = 4) and (H) representative western blot analysis of P-ERM expression level (left), and quantification of P-ERM expression level, normalized to actin (right, each circle represents a single donor, n = 5, SD is shown). (I and J) On day 6 of differentiation, macrophages were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 7 days after infection. (I) Quantification of the fusion index (each circle represents a single donor, n = 4) and (J) representative western blot analysis of P-ERM expression level (left) and quantification of P-ERM expression level, normalized to actin (right). Each circle represents a single donor, n = 6, SDs are shown. Predicted molecular weights are indicated on western blots. Statistical analyses: (D and E) one-way ANOVA and then Tukey multiple comparison tests. P value is indicated on the graphs, *P ≤ 0.05. Source data are available for this figure: .
D Luciferin Potassium Salt, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d luciferin potassium salt/product/Gold Biotechnology Inc
Average 98 stars, based on 1 article reviews
d luciferin potassium salt - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

94
Croda International Plc 1 oleoyl 2 hydroxy sn glycero 3 phospho l serine
(Related to ). (A and B) Depletion of meosin by siRNA in hOC. Western blot analysis of moesin and activated ERM (P-ERM) expression level in hOC after treatment on day 0 with nontargeting siRNA (siCTL) or siRNA targeting moesin (siM), on days 3, 6, and 10 of differentiation. (A) Representative experiment and (B) quantification of moesin (left) and P-ERM (right) expression level normalized to actin. Each circle represents a single donor, n = 7–8, SDs are shown. (C–E) Effect of <t>LPC</t> treatment on hOC fusion and activated ERM expression level (P-ERM). On day 6 of differentiation, hOC were treated with LPC (+LPC, 17 h), or treated and then washed (90 min) (+/− LPC) or no treated (control, CTL). (C and D) Microscopy analysis of hOC fusion. (C) Representative microscopy images: F-actin (phalloidin, white) and nuclei (DAPI, cyan). Scale bar, 50 µm. (D) Quantification of fusion index (left) and area occupied by multinucleated OC (right). Each circle represents a single donor, n =3–4. (E) Western blot analysis of P-ERM expression level in each condition, normalized to actin. Representative blot (left panel) and quantification (right panel). Each circle represents a single donor, n = 4. (F) P-ERM signal by western blot analysis in murine inflammatory osteoclasts (DC-OC) versus control osteoclasts (MN-OC). See material and methods. Representative blot of P-ERM expression level in each condition (upper panel) and quantification of P-ERM expression level, normalized to actin (lower panel). Each circle represents a single mouse, n = 4, SDs are shown. (G–J) Effect of HIV infection on activated ERM expression level (P-ERM) in hOC (G and H) and macrophages (I and J). (G and H) On day 6 of differentiation, hOC were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 8 days after infection. (G) Quantification of the fusion index (each circle represents a single donor, n = 4) and (H) representative western blot analysis of P-ERM expression level (left), and quantification of P-ERM expression level, normalized to actin (right, each circle represents a single donor, n = 5, SD is shown). (I and J) On day 6 of differentiation, macrophages were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 7 days after infection. (I) Quantification of the fusion index (each circle represents a single donor, n = 4) and (J) representative western blot analysis of P-ERM expression level (left) and quantification of P-ERM expression level, normalized to actin (right). Each circle represents a single donor, n = 6, SDs are shown. Predicted molecular weights are indicated on western blots. Statistical analyses: (D and E) one-way ANOVA and then Tukey multiple comparison tests. P value is indicated on the graphs, *P ≤ 0.05. Source data are available for this figure: .
1 Oleoyl 2 Hydroxy Sn Glycero 3 Phospho L Serine, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1 oleoyl 2 hydroxy sn glycero 3 phospho l serine/product/Croda International Plc
Average 94 stars, based on 1 article reviews
1 oleoyl 2 hydroxy sn glycero 3 phospho l serine - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


(Related to ). (A and B) Depletion of meosin by siRNA in hOC. Western blot analysis of moesin and activated ERM (P-ERM) expression level in hOC after treatment on day 0 with nontargeting siRNA (siCTL) or siRNA targeting moesin (siM), on days 3, 6, and 10 of differentiation. (A) Representative experiment and (B) quantification of moesin (left) and P-ERM (right) expression level normalized to actin. Each circle represents a single donor, n = 7–8, SDs are shown. (C–E) Effect of LPC treatment on hOC fusion and activated ERM expression level (P-ERM). On day 6 of differentiation, hOC were treated with LPC (+LPC, 17 h), or treated and then washed (90 min) (+/− LPC) or no treated (control, CTL). (C and D) Microscopy analysis of hOC fusion. (C) Representative microscopy images: F-actin (phalloidin, white) and nuclei (DAPI, cyan). Scale bar, 50 µm. (D) Quantification of fusion index (left) and area occupied by multinucleated OC (right). Each circle represents a single donor, n =3–4. (E) Western blot analysis of P-ERM expression level in each condition, normalized to actin. Representative blot (left panel) and quantification (right panel). Each circle represents a single donor, n = 4. (F) P-ERM signal by western blot analysis in murine inflammatory osteoclasts (DC-OC) versus control osteoclasts (MN-OC). See material and methods. Representative blot of P-ERM expression level in each condition (upper panel) and quantification of P-ERM expression level, normalized to actin (lower panel). Each circle represents a single mouse, n = 4, SDs are shown. (G–J) Effect of HIV infection on activated ERM expression level (P-ERM) in hOC (G and H) and macrophages (I and J). (G and H) On day 6 of differentiation, hOC were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 8 days after infection. (G) Quantification of the fusion index (each circle represents a single donor, n = 4) and (H) representative western blot analysis of P-ERM expression level (left), and quantification of P-ERM expression level, normalized to actin (right, each circle represents a single donor, n = 5, SD is shown). (I and J) On day 6 of differentiation, macrophages were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 7 days after infection. (I) Quantification of the fusion index (each circle represents a single donor, n = 4) and (J) representative western blot analysis of P-ERM expression level (left) and quantification of P-ERM expression level, normalized to actin (right). Each circle represents a single donor, n = 6, SDs are shown. Predicted molecular weights are indicated on western blots. Statistical analyses: (D and E) one-way ANOVA and then Tukey multiple comparison tests. P value is indicated on the graphs, *P ≤ 0.05. Source data are available for this figure: .

Journal: The Journal of Cell Biology

Article Title: Moesin controls cell–cell fusion and osteoclast function

doi: 10.1083/jcb.202409169

Figure Lengend Snippet: (Related to ). (A and B) Depletion of meosin by siRNA in hOC. Western blot analysis of moesin and activated ERM (P-ERM) expression level in hOC after treatment on day 0 with nontargeting siRNA (siCTL) or siRNA targeting moesin (siM), on days 3, 6, and 10 of differentiation. (A) Representative experiment and (B) quantification of moesin (left) and P-ERM (right) expression level normalized to actin. Each circle represents a single donor, n = 7–8, SDs are shown. (C–E) Effect of LPC treatment on hOC fusion and activated ERM expression level (P-ERM). On day 6 of differentiation, hOC were treated with LPC (+LPC, 17 h), or treated and then washed (90 min) (+/− LPC) or no treated (control, CTL). (C and D) Microscopy analysis of hOC fusion. (C) Representative microscopy images: F-actin (phalloidin, white) and nuclei (DAPI, cyan). Scale bar, 50 µm. (D) Quantification of fusion index (left) and area occupied by multinucleated OC (right). Each circle represents a single donor, n =3–4. (E) Western blot analysis of P-ERM expression level in each condition, normalized to actin. Representative blot (left panel) and quantification (right panel). Each circle represents a single donor, n = 4. (F) P-ERM signal by western blot analysis in murine inflammatory osteoclasts (DC-OC) versus control osteoclasts (MN-OC). See material and methods. Representative blot of P-ERM expression level in each condition (upper panel) and quantification of P-ERM expression level, normalized to actin (lower panel). Each circle represents a single mouse, n = 4, SDs are shown. (G–J) Effect of HIV infection on activated ERM expression level (P-ERM) in hOC (G and H) and macrophages (I and J). (G and H) On day 6 of differentiation, hOC were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 8 days after infection. (G) Quantification of the fusion index (each circle represents a single donor, n = 4) and (H) representative western blot analysis of P-ERM expression level (left), and quantification of P-ERM expression level, normalized to actin (right, each circle represents a single donor, n = 5, SD is shown). (I and J) On day 6 of differentiation, macrophages were infected with the viral strain NLAD8-VSVG (+HIV-1) or not (CTL) and analyzed 7 days after infection. (I) Quantification of the fusion index (each circle represents a single donor, n = 4) and (J) representative western blot analysis of P-ERM expression level (left) and quantification of P-ERM expression level, normalized to actin (right). Each circle represents a single donor, n = 6, SDs are shown. Predicted molecular weights are indicated on western blots. Statistical analyses: (D and E) one-way ANOVA and then Tukey multiple comparison tests. P value is indicated on the graphs, *P ≤ 0.05. Source data are available for this figure: .

Article Snippet: TAT-C3 was added at 48 h, Y27632 at 24 h, NSC23766 and ML141 at 10 h, and calyculin and staurosporine at 10 min. Osteoclast fusion was synchronized with LPC (1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine, #855475; Avanti Polar Lipids) ( ).

Techniques: Western Blot, Expressing, Control, Microscopy, Infection, Comparison